{"id":"W4411284611","doi":"10.1038/s44161-025-00657-7","title":"Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction","year":2025,"lang":"en","type":"article","venue":"Nature Cardiovascular Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"Astellas Pharma; Novo Nordisk; Servier; Horizon Therapeutics; Moderna; Impulse Dynamics; Cytokinetics; Regeneron Pharmaceuticals; National Heart, Lung, and Blood Institute; Pfizer; LivaNova; Boston Scientific Corporation; American Regent; Sanofi; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim; Amgen; National Institutes of Health; Novavax","keywords":"Empagliflozin; Myocardial infarction; Medicine; Cardiology; Internal medicine; Diabetes mellitus; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005924393,0.001086561,0.002893371,0.0004306716,0.0003014604,0.001201661,0.000507851,0.0008908899,0.004689701],"category_scores_gemma":[0.006146138,0.0002704627,0.003559262,0.0004892657,0.000397312,0.0005992165,0.0005984754,0.002102034,0.0004653774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003083266,"about_ca_system_score_gemma":0.000529645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005145089,"about_ca_topic_score_gemma":0.0007240563,"domain_scores_codex":[0.9966259,0.002317062,0.0001988153,0.0003722534,0.0002575102,0.0002286256],"domain_scores_gemma":[0.9970502,0.001232352,0.0006258142,0.0004401266,0.0002826938,0.0003688464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9467717,0.001818372,0.01533453,0.0009196281,0.009115378,0.000102196,0.00003746416,0.0007941863,0.002344942,0.0004646582,0.005567033,0.01672992],"study_design_scores_gemma":[0.6619944,0.07734916,0.2140035,0.0001972591,0.02300619,0.0002669934,0.00005913582,0.008226588,0.004483821,0.00262912,0.007693071,0.00009061384],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741337,0.007314193,0.003070033,0.0008307311,0.000521393,0.001457295,0.007746102,0.0001835486,0.004742932],"genre_scores_gemma":[0.9883029,0.0006850171,0.001143815,0.000616384,0.0004473888,0.001376426,0.005582284,0.0000277447,0.001818117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005924393,"threshold_uncertainty_score":0.03133154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01368456965825935,"score_gpt":0.3210841938003368,"score_spread":0.3073996241420774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}